Pacific Biosciences Of California (PACB) Total Debt Growth (3y) (2013 - 2022)
Pacific Biosciences Of California (PACB) Total Debt Growth (3y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -0.32% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 2.61% |
| 10 | Pacific Biosciences Of California | 414.38 Mn | 138.42 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 122.65% |
| Dec 31, 2021 | -35.64% |
| Dec 31, 2019 | -0.64% |
| Dec 31, 2018 | -0.65% |
| Sep 30, 2018 | -0.96% |
| Jun 30, 2018 | -1.03% |
| Mar 31, 2018 | -1.10% |
| Dec 31, 2017 | -0.86% |
| Sep 30, 2017 | -9.08% |
| Jun 30, 2017 | -8.69% |
| Mar 31, 2017 | -0.55% |
| Dec 31, 2016 | 6.46% |
| Sep 30, 2016 | 6.24% |
| Jun 30, 2016 | 6.01% |
| Mar 31, 2015 | 70.46% |
| Dec 31, 2014 | 68.47% |
| Sep 30, 2014 | 67.59% |
| Jun 30, 2014 | 66.22% |
| Dec 31, 2013 | 63.80% |